SCHEMBL16017243

SCHEMBL16017243

Cn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)c2c(Cl)c(C(C)(F)F)nn2C)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
CYP3A4 P08684 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
POLB P06746 2/20 0.42
MAPT P10636 5/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
STIM1 Q13586 2/20 0.40
ORAI1 Q96D31 2/20 0.40
CYP2C9 P11712 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16019779 0.94 ALDH1A1 (0.45) ALDH1A1CYP3A4CYP1A2CYP2C19POLB
SCHEMBL16019774 0.89 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP1A2CYP2C19POLB
SCHEMBL16017250 0.85 RAF1 (0.42) ALDH1A1CYP3A4CYP1A2CYP2C19POLB
SCHEMBL29420773 0.83 MAPT (0.52) ALDH1A1CYP1A2MAPTMAPK1SMN1; SMN2
SCHEMBL16017420 0.83 MAPT (0.52) ALDH1A1CYP1A2MAPTMAPK1SMN1; SMN2
SCHEMBL16017176 0.83 STIM1 (0.41) ALDH1A1CYP3A4CYP1A2CYP2C19POLB
SCHEMBL23843002 0.80 HTT (0.51) ALDH1A1CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL16008936 0.79 STIM1 (0.52) ALDH1A1CYP3A4CYP1A2CYP2C19POLB
SCHEMBL16017183 0.79 CRACR2A (0.55) ALDH1A1CYP3A4CYP1A2CYP2C19MAPT
SCHEMBL14887389 0.79 BACE1 (0.45) ALDH1A1POLBMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885CYP3A4 4329/4885CYP1A2 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.